Page last updated: 2024-08-17

cordycepin and Astrocytoma, Grade IV

cordycepin has been researched along with Astrocytoma, Grade IV in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (71.43)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Chen, J; Liang, RS; Liu, S; Wang, CH; Zhang, Q; Zhuang, BB; Zhuang, YD1
Chen, J; Shi, SS; Zhang, GL; Zhang, Q; Zheng, SX; Zhuang, BB1
Chaicharoenaudomrung, N; Jaroonwitchawan, T; Noisa, P1
Bai, Y; Bi, Y; Chen, Y; Li, H; Song, Y; Sun, Y; Yi, D; Zhao, G; Zhong, S1
Chaicharoenaudomrung, N; Heebkaew, N; Kunhorm, P; Noisa, P; Promjantuek, W; Rujanapun, N1
Baik, JS; Kim, CH; Kim, DH; Kim, KS; Lee, YC; Mun, SW; Park, MK; Park, SJ; Yoon, HK1
Chen, Y; Cheng, YC; Hsieh, CH; Hueng, DY; Tsai, WC1

Other Studies

7 other study(ies) available for cordycepin and Astrocytoma, Grade IV

ArticleYear
Exploring the mechanism of cordycepin combined with doxorubicin in treating glioblastoma based on network pharmacology and biological verification.
    PeerJ, 2022, Volume: 10

    Topics: Cell Line, Tumor; Doxorubicin; Glioblastoma; Humans; Network Pharmacology; Transcription Factors

2022
Cordycepin improves sensitivity to temozolomide in glioblastoma cells by down-regulating MYC.
    Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:17

    Topics: Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Drug Combinations; Glioblastoma; Humans; MicroRNAs; Myeloid Cell Leukemia Sequence 1 Protein; Phosphatidylinositol 3-Kinases; Proteoglycans; Proto-Oncogene Proteins c-akt; RNA-Binding Proteins; Temozolomide

2023
Cordycepin induces apoptotic cell death of human brain cancer through the modulation of autophagy.
    Toxicology in vitro : an international journal published in association with BIBRA, 2018, Volume: 46

    Topics: Apoptosis; Autophagy; Brain Neoplasms; Cells, Cultured; Deoxyadenosines; Glioblastoma; Humans; Molecular Structure; Neuroblastoma; Neurons; Reactive Oxygen Species

2018
Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Molecular pharmaceutics, 2018, 11-05, Volume: 15, Issue:11

    Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Deoxyadenosines; Drug Resistance, Neoplasm; Drug Synergism; Glioblastoma; Humans; Male; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Temozolomide; Treatment Outcome; Xenograft Model Antitumor Assays

2018
Fabrication of 3D calcium-alginate scaffolds for human glioblastoma modeling and anticancer drug response evaluation.
    Journal of cellular physiology, 2019, Volume: 234, Issue:11

    Topics: Alginates; Antineoplastic Agents; Calcium; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Deoxyadenosines; Doxorubicin; Glioblastoma; Humans; Neoplastic Stem Cells; Tissue Scaffolds; Vascular Endothelial Growth Factor A

2019
Apoptotic Effects of Cordycepin Through the Extrinsic Pathway and p38 MAPK Activation in Human Glioblastoma U87MG Cells.
    Journal of microbiology and biotechnology, 2016, Volume: 26, Issue:2

    Topics: Antifungal Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 8; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyadenosines; Fas Ligand Protein; Glioblastoma; Humans; p38 Mitogen-Activated Protein Kinases; Signal Transduction

2016
Cordycepin inhibits migration of human glioblastoma cells by affecting lysosomal degradation and protein phosphatase activation.
    The Journal of nutritional biochemistry, 2017, Volume: 41

    Topics: Ammonium Chloride; Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Deoxyadenosines; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Lysosomes; Marine Toxins; Mice, Nude; Neoplasm Proteins; Okadaic Acid; Oxazoles; Phosphoprotein Phosphatases; Proteolysis; Tumor Burden; Xenograft Model Antitumor Assays

2017